Clinical Trial Update: FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether oral lutein supplementation influences macular pigment in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein (lutein)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Age Related Macular Degeneration | Phase 4 | Status: COMPLETED